BlackRock’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,548,774
Closed -$29.2M 5481
2023
Q4
$29.2M Buy
11,548,774
+600,516
+5% +$1.4M ﹤0.01% 2797
2023
Q3
$26.2M Sell
10,948,258
-15,158
-0.1% -$33.6K ﹤0.01% 2786
2023
Q2
$25.3M Buy
10,963,416
+284,778
+3% +$804K ﹤0.01% 2887
2023
Q1
$27.2M Buy
10,678,638
+410,357
+4% +$1.18M ﹤0.01% 2814
2022
Q4
$25.8M Buy
10,268,281
+529,068
+5% +$1.48M ﹤0.01% 2891
2022
Q3
$28.2M Sell
9,739,213
-31,014
-0.3% -$131K ﹤0.01% 2840
2022
Q2
$44.2M Buy
9,770,227
+7,712,881
+375% +$45.9M ﹤0.01% 2570
2022
Q1
$16.5M Buy
2,057,346
+98,990
+5% +$873K ﹤0.01% 3295
2021
Q4
$22.8M Buy
+1,958,356
New +$23.5M ﹤0.01% 3186

BlackRock's SLGC Position: Q1 2024 in Review

BlackRock sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 11,548,774 shares — an estimated $29.2M sold.

BlackRock first reported a position in SLGC in Q4 2021 and held it in 9 quarters. The position peaked at $44.2M in Q2 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • BlackRock reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • BlackRock sold 11,548,774 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $29.2M.
  • BlackRock first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 9 quarters.
  • BlackRock's SomaLogic, Inc. Class A Common Stock position peaked at $44.2M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.